학술논문

Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment: Is there a rationale for a clinical trial?
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2013, 31 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755